US Stock MarketDetailed Quotes

TELA TELA Bio

Watchlist
  • 1.235
  • -0.135-9.85%
Close Mar 28 16:00 ET
  • 1.230
  • -0.005-0.41%
Post 20:01 ET
48.85MMarket Cap-0.93P/E (TTM)

TELA Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
18.56%69.3M
3.83%17.65M
25.94%18.96M
11.02%16.09M
39.42%16.6M
41.13%58.45M
46.26%17M
34.89%15.05M
39.29%14.49M
44.68%11.91M
Operating revenue
18.56%69.3M
3.83%17.65M
25.94%18.96M
11.02%16.09M
39.42%16.6M
41.13%58.45M
46.26%17M
34.89%15.05M
39.29%14.49M
44.68%11.91M
Cost of revenue
24.38%22.81M
19.61%6.43M
30.80%6.1M
16.89%5.02M
31.31%5.27M
27.60%18.34M
55.95%5.37M
21.43%4.66M
11.33%4.29M
24.10%4.01M
Gross profit
15.90%46.49M
-3.47%11.22M
23.77%12.86M
8.55%11.07M
43.53%11.34M
48.32%40.11M
42.17%11.62M
41.95%10.39M
55.74%10.2M
57.99%7.9M
Operating expense
4.75%88.18M
-18.10%19.58M
8.04%22.22M
10.12%22.64M
23.97%23.74M
27.46%84.19M
35.69%23.9M
22.40%20.57M
22.49%20.56M
29.03%19.15M
Selling and administrative expenses
6.44%79.37M
-17.30%17.55M
10.73%20.16M
12.58%20.32M
24.85%21.35M
30.56%74.57M
42.50%21.22M
23.79%18.2M
22.91%18.05M
33.22%17.1M
-Selling and marketing expense
8.32%64.65M
-18.68%13.96M
13.80%16.47M
14.56%16.7M
30.11%17.52M
37.98%59.68M
47.37%17.16M
29.56%14.47M
31.86%14.58M
43.59%13.47M
-General and administrative expense
-1.11%14.72M
-11.45%3.59M
-1.21%3.68M
4.29%3.62M
5.37%3.83M
7.39%14.89M
25.02%4.05M
5.55%3.73M
-4.35%3.47M
5.09%3.63M
Research and development costs
-8.38%8.81M
-24.43%2.03M
-12.67%2.07M
-7.60%2.32M
16.62%2.39M
7.63%9.62M
-1.50%2.69M
12.65%2.37M
19.60%2.51M
2.24%2.05M
Operating profit
5.40%-41.7M
31.96%-8.35M
8.01%-9.37M
-11.66%-11.57M
-10.24%-12.41M
-12.99%-44.08M
-30.08%-12.28M
-7.32%-10.18M
-1.22%-10.36M
-14.32%-11.25M
Net non-operating interest income expense
-1.28%-5.29M
4.61%-1.28M
-0.75%-1.34M
-2.54%-1.33M
-6.90%-1.33M
-28.93%-5.22M
-14.57%-1.35M
-29.26%-1.33M
-38.97%-1.3M
-36.77%-1.25M
Non-operating interest expense
1.28%5.29M
-4.61%1.28M
0.75%1.34M
2.54%1.33M
6.90%1.33M
28.93%5.22M
14.57%1.35M
29.26%1.33M
38.97%1.3M
36.77%1.25M
Other net income (expense)
241.69%9M
-61.12%285K
-39.61%337K
-65.40%301K
1,607.61%8.08M
312.76%2.63M
15.62%733K
386.15%558K
155.41%870K
542.06%473K
Special income (charges)
--7.58M
--0
--0
--0
--7.58M
--0
--0
--0
--0
--0
-Gain on sale of business
--7.58M
--0
--0
--0
--7.58M
--0
--0
--0
--0
--0
Other non- operating income (expenses)
-46.09%1.42M
-61.12%285K
-39.61%337K
-65.40%301K
5.07%497K
26,440.00%2.63M
15.62%733K
386.15%558K
354.39%870K
542.06%473K
Income before tax
18.60%-37.99M
27.45%-9.35M
5.34%-10.37M
-16.77%-12.6M
52.93%-5.66M
-5.35%-46.66M
-29.17%-12.89M
-2.27%-10.96M
15.31%-10.79M
-10.73%-12.03M
Income tax
-144K
0
Net income
18.91%-37.84M
28.56%-9.21M
5.34%-10.37M
-16.77%-12.6M
52.93%-5.66M
-5.35%-46.66M
-29.17%-12.89M
-2.27%-10.96M
15.31%-10.79M
-10.73%-12.03M
Net income continuous Operations
18.91%-37.84M
28.56%-9.21M
5.34%-10.37M
-16.77%-12.6M
52.93%-5.66M
-5.35%-46.66M
-29.17%-12.89M
-2.27%-10.96M
15.31%-10.79M
-10.73%-12.03M
Minority interest income
Net income attributable to the parent company
18.91%-37.84M
28.56%-9.21M
5.34%-10.37M
-16.77%-12.6M
52.93%-5.66M
-5.35%-46.66M
-29.17%-12.89M
-2.27%-10.96M
15.31%-10.79M
-10.73%-12.03M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
18.91%-37.84M
28.56%-9.21M
5.34%-10.37M
-16.77%-12.6M
52.93%-5.66M
-5.35%-46.66M
-29.17%-12.89M
-2.27%-10.96M
15.31%-10.79M
-10.73%-12.03M
Basic earnings per share
34.80%-1.33
56.60%-0.23
6.67%-0.42
-10.87%-0.51
63.49%-0.23
25.00%-2.04
-1.92%-0.53
29.69%-0.45
47.73%-0.46
16.00%-0.63
Diluted earnings per share
34.80%-1.33
56.60%-0.23
6.67%-0.42
-10.87%-0.51
63.49%-0.23
25.00%-2.04
-1.92%-0.53
29.69%-0.45
47.73%-0.46
16.00%-0.63
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 18.56%69.3M3.83%17.65M25.94%18.96M11.02%16.09M39.42%16.6M41.13%58.45M46.26%17M34.89%15.05M39.29%14.49M44.68%11.91M
Operating revenue 18.56%69.3M3.83%17.65M25.94%18.96M11.02%16.09M39.42%16.6M41.13%58.45M46.26%17M34.89%15.05M39.29%14.49M44.68%11.91M
Cost of revenue 24.38%22.81M19.61%6.43M30.80%6.1M16.89%5.02M31.31%5.27M27.60%18.34M55.95%5.37M21.43%4.66M11.33%4.29M24.10%4.01M
Gross profit 15.90%46.49M-3.47%11.22M23.77%12.86M8.55%11.07M43.53%11.34M48.32%40.11M42.17%11.62M41.95%10.39M55.74%10.2M57.99%7.9M
Operating expense 4.75%88.18M-18.10%19.58M8.04%22.22M10.12%22.64M23.97%23.74M27.46%84.19M35.69%23.9M22.40%20.57M22.49%20.56M29.03%19.15M
Selling and administrative expenses 6.44%79.37M-17.30%17.55M10.73%20.16M12.58%20.32M24.85%21.35M30.56%74.57M42.50%21.22M23.79%18.2M22.91%18.05M33.22%17.1M
-Selling and marketing expense 8.32%64.65M-18.68%13.96M13.80%16.47M14.56%16.7M30.11%17.52M37.98%59.68M47.37%17.16M29.56%14.47M31.86%14.58M43.59%13.47M
-General and administrative expense -1.11%14.72M-11.45%3.59M-1.21%3.68M4.29%3.62M5.37%3.83M7.39%14.89M25.02%4.05M5.55%3.73M-4.35%3.47M5.09%3.63M
Research and development costs -8.38%8.81M-24.43%2.03M-12.67%2.07M-7.60%2.32M16.62%2.39M7.63%9.62M-1.50%2.69M12.65%2.37M19.60%2.51M2.24%2.05M
Operating profit 5.40%-41.7M31.96%-8.35M8.01%-9.37M-11.66%-11.57M-10.24%-12.41M-12.99%-44.08M-30.08%-12.28M-7.32%-10.18M-1.22%-10.36M-14.32%-11.25M
Net non-operating interest income expense -1.28%-5.29M4.61%-1.28M-0.75%-1.34M-2.54%-1.33M-6.90%-1.33M-28.93%-5.22M-14.57%-1.35M-29.26%-1.33M-38.97%-1.3M-36.77%-1.25M
Non-operating interest expense 1.28%5.29M-4.61%1.28M0.75%1.34M2.54%1.33M6.90%1.33M28.93%5.22M14.57%1.35M29.26%1.33M38.97%1.3M36.77%1.25M
Other net income (expense) 241.69%9M-61.12%285K-39.61%337K-65.40%301K1,607.61%8.08M312.76%2.63M15.62%733K386.15%558K155.41%870K542.06%473K
Special income (charges) --7.58M--0--0--0--7.58M--0--0--0--0--0
-Gain on sale of business --7.58M--0--0--0--7.58M--0--0--0--0--0
Other non- operating income (expenses) -46.09%1.42M-61.12%285K-39.61%337K-65.40%301K5.07%497K26,440.00%2.63M15.62%733K386.15%558K354.39%870K542.06%473K
Income before tax 18.60%-37.99M27.45%-9.35M5.34%-10.37M-16.77%-12.6M52.93%-5.66M-5.35%-46.66M-29.17%-12.89M-2.27%-10.96M15.31%-10.79M-10.73%-12.03M
Income tax -144K0
Net income 18.91%-37.84M28.56%-9.21M5.34%-10.37M-16.77%-12.6M52.93%-5.66M-5.35%-46.66M-29.17%-12.89M-2.27%-10.96M15.31%-10.79M-10.73%-12.03M
Net income continuous Operations 18.91%-37.84M28.56%-9.21M5.34%-10.37M-16.77%-12.6M52.93%-5.66M-5.35%-46.66M-29.17%-12.89M-2.27%-10.96M15.31%-10.79M-10.73%-12.03M
Minority interest income
Net income attributable to the parent company 18.91%-37.84M28.56%-9.21M5.34%-10.37M-16.77%-12.6M52.93%-5.66M-5.35%-46.66M-29.17%-12.89M-2.27%-10.96M15.31%-10.79M-10.73%-12.03M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 18.91%-37.84M28.56%-9.21M5.34%-10.37M-16.77%-12.6M52.93%-5.66M-5.35%-46.66M-29.17%-12.89M-2.27%-10.96M15.31%-10.79M-10.73%-12.03M
Basic earnings per share 34.80%-1.3356.60%-0.236.67%-0.42-10.87%-0.5163.49%-0.2325.00%-2.04-1.92%-0.5329.69%-0.4547.73%-0.4616.00%-0.63
Diluted earnings per share 34.80%-1.3356.60%-0.236.67%-0.42-10.87%-0.5163.49%-0.2325.00%-2.04-1.92%-0.5329.69%-0.4547.73%-0.4616.00%-0.63
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Petroleo Brasileiro SA Petrobras
PBR
-0.07%
Vale SA
VALE
-1.28%
NVIDIA
NVDA
-1.58%
Ecopetrol
EC
-1.64%
Taylor Morrison Home
TMHC
-2.11%

Unlock the Full List